Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-50
Closed -$226 1841
2025
Q4
$226 Buy
+50
New +$256 ﹤0.01% 1459

SHP Wealth Management's CVAC Position: Q1 2026 in Review

SHP Wealth Management sold out of CureVac (CVAC) in Q1 2026, closing a stake of 50 shares — an estimated $226 sold.

SHP Wealth Management first reported a position in CVAC in Q4 2025 and held it in 1 quarter. The position peaked at $226 in Q4 2025. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.

  • SHP Wealth Management reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
  • SHP Wealth Management sold 50 CureVac shares in Q1 2026, an estimated $226.
  • SHP Wealth Management first reported a position in CureVac in Q4 2025 and held it in 1 quarter.
  • SHP Wealth Management's CureVac position peaked at $226 in Q4 2025.
  • 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.

Based on SHP Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.